Skip to main content
. Author manuscript; available in PMC: 2015 Feb 19.
Published in final edited form as: Am J Transplant. 2014 Oct 30;15(1):149–154. doi: 10.1111/ajt.12992

Table 1.

Kidney transplantation (KT) recipients, stratified by frailty status at the time of transplantation (n = 537)

Nonfrail (n = 253) Intermediately frail (n = 177) Frail (n = 107) p-Value
Recipient
    Age 50.7 (14.0) 54.5 (13.7) 55.8 (14.0) 0.002
    African American race 37.6 39.6 41.1 0.8
    Female sex 39.9 40.7 39.3 0.9
    BMI (kg/m2) 27.3 (6.0) 27.6 (5.7) 27.6 (5.9) 0.9
    Diabetes 13.8 22.0 20.6 0.1
    Time on dialysis (years) 2.0 (0.4–4.4) 2.0 (0.5–3.8) 1.7 (0.4–3.7) 0.5
    HCV positive 8.3 7.9 12.2 0.4
    Previous transplant 18.2 13.0 17.8 0.3
Transplant
    PRA = 0 38.3 36.2 59.8 0.8
    0 HLA mismatch 4.0 5.7 3.7 0.7
    Preemptive KT 21.3 13.6 17.8 0.1
    Cold ischemia time 9.7 (1.7–24.0) 12.8 (1.6–28.6) 10.5 (2.1–26.4) 0.5
Donor
    Live donor 48.2 42.8 42.1 0.3
    ECD 4.0 4.0 12.2 0.01
    DCD 7.5 9.6 8.4 0.7
    White race 73.9 71.2 74.8 0.8
    History of hypertension 14.2 15.3 20.6 0.3
    Creatinine > 1.5 15.8 17.0 12.2 0.6

Nonfrail was defined as a score of 0 or 1, intermediately frail was defined as a score of 2 and frail was defined as a score of 3 or higher. The mean [SD] are presented for age and BMI. The median and interquartile range are presented for time on dialysis and cold ischemia time. All other measures are %. HCV, hepatitis C virus; PRA, panel reactive antibody; ECD, deceased expanded criteria; DCD, donation after cardiac death donor.